Moderna’s Bob Langer and AI Pioneer Yann LeCun Join Board of Cellular Intelligence, Bringing AI Into Medicine via a Parkinson’s Drug

Moderna's Bob Langer and AI pioneer Yann LeCun join board of Cellular Intelligence, bringing AI into medicine via a Parkinson's drug

Cellular Intelligence is trying to build an AI model that can predict and eventually control how living cells behave, the same way AI models predict text or images, in hopes of making new medicines faster and cheaper to develop. The company took a step toward that goal Monday, announcing that Moderna co-founder Robert “Bob” Langer and Turing Award-winning AI researcher Yann LeCun have joined its scientific advisory board, along with Jens Nielsen…

Moderna’s Bob Langer and Yann LeCun join Cellular Intelligence advisory board to advance AI in medicine

The advisory board's expertise could accelerate breakthroughs in AI-driven cell biology, potentially revolutionizing regenerative medicine. The post Moderna’s Bob Langer and Yann LeCun join Cellular Intelligence advisory board to advance AI in medicine appeared first on Crypto Briefing .

Moderna’s Bob Langer and AMI’s Yann LeCun Cellular Intelligence’s board, bringing AI into medicine

Cellular Intelligence is trying to build an AI model that can predict and eventually control how living cells behave, the same way AI models predict text or images, in hopes of making new medicines faster and cheaper to develop. The company took a step toward that goal Monday, announcing that Moderna co-founder Robert “Bob” Langer […]

Moderna’s Bob Langer and AI pioneer Yann LeCun join board of Cellular Intelligence, bringing AI into medicine via a Parkinson’s drug

Cellular Intelligence is trying to build an AI model that can predict and eventually control how living cells behave, the same way AI models predict text or images, in hopes of making new medicines faster and cheaper to develop. The company took a step toward that goal Monday, announcing that…